CompletedNot Applicable

Impact of Probiotic Supplementation on Exercise Endurance Among Non-elite Athletes

United States29 participantsStarted 2021-03-12

Plain-language summary

The aim of this trial is to evaluate the effects of 6-week administration of probiotics on running performance among non-elite athletes. It is hypothesized that participants receiving probiotics may improve their running performance at an endurance test compared to their placebo-receiving counterparts.

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy adults between 18-45 years old
✓. Regularly participate in running and cross-training, and willing to maintain this level of training throughout the study. Participant must satisfy all three sub-criteria:
✓. 3-5 days per week of running or cross-training AND
✓. 45 minutes - 1.5 hours per activity session AND
✓. Run ≥15 miles per week
✓. VO2 max values that in the 60-85th percentile (good-excellent health) range according to ACSM guidelines \[1\].

Exclusion criteria

✕. Any physician-diagnosed diseases that would impact exercise performance or participation, including gastrointestinal disease, heart/cardiopulmonary disease, diabetes, thyroid disease, hypogonadism, hepatorenal disease, musculoskeletal disorder, neuromuscular/neurological disease, autoimmune disease, cancer, peptic ulcers or anemia.
✕. Professional or elite athletes.
✕. Use of any antibiotic drug within 4 weeks of randomization. Volunteer could be eligible to participate after a 2-week washout period.
✕. Currently smoking (including vaping)
✕. Pregnant, planning to get pregnant, or currently breastfeeding.
✕. Lactose intolerance and/or milk, soy or yeast allergy.

What they're measuring

Time-to exhaustion during submaximal treadmill test

Timeframe: 6 weeks

Trial details

NCT IDNCT04588142

SponsorLallemand Health Solutions

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2021-12-23

View on ClinicalTrials.gov More Exercise Endurance trials